Society for Clinical Vascular Surgery
December 22, 2008

Management of Renal Artery Aneurysms: Surgery, Endovascular Therapy and Observation

Back to Annual Meeting
Back to Program
Neal S. Cayne, MD, caron Rockman, md, Stephen Bauer, md, Frank Veith, md, tom maldonado, md, patrick lamparello, md, mark adelman, md, glenn jacobowitz, md, tom riles, md.
NYU Medical Center, New York, NY, USA.

OBJECTIVES: This study reports our experience with treatment and observation of renal artery aneurysms(RAAs).
METHODS: We performed a retrospective review of all patients evaluated by the New York University Vascular Surgery Department from 1998 to 2008. Thirty-three patients(17 males/16 females) were identified with RAAs. Average age was 63±16years. Nineteen patients underwent either open surgery(n=8) or percutaneous intervention(n=11). Indications for RAA treatment were size >2.0 cm(18/19), identification of the RAA during pregnancy(1/19), RAA in a non-pregnant female of child bearing age(4/19), symptoms of hypertension and/or pain (7/19) and a concomitant ipsilateral renal cell cancer(1/19). The remaining fourteen RAA patients were observed.
RESULTS: Six of 11 patients treated via an endovascular approach underwent successful exclusion with placement of an endovascular graft(4 Viabahn, 2 Atrium). The remaining 5 endovascular patients had saccular aneurysms that were amenable to coil embolization. Seven of the 8 patients requiring open surgery for their RAA had a primary aneurysmectomy and arterioplasty with, or without vein patch closure. One patient required open surgery with nephrectomy for a concomitant ipsilateral renal cell cancer. Average length of stay was 2.3 days for the endovascular patients and 6.2 days for the open surgical patients. There was no 30-day mortality or decline in renal function in either the endovascular or open surgical group. All 6 stent grafts remain patent with excluded RAAs at 23 ± 18 months(range 6-48 months). The observed group had an average RAA size of 1.7 cm±.5cm, with an average RAA growth rate of <1mm/year. Mean follow-up for the observation group was 49 months. There were no aneurysm ruptures or aneurysm related deaths.
CONCLUSIONS: RAAs can be safely treated via an endovascular or open approach. In appropriately selected patients, an endovascular approach can offer successful exclusion with a shorter hospital stay. RAAs <2.0 cm have a slow rate of growth and may be observed in asymptomatic patients who are not females in their child bearing years
.


Back to Annual Meeting
Back to Program